300199.SZ
Hybio Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 22.17
−4.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 50.00x
- P/E 2027E
- 36.15x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 535.45x
- PEG TTM
- —
- Price / book
- 23.03x
- Price / sales
- 21.72x
- Price / cash flow
- 78.65x
Enterprise value
- Enterprise value
- CNY 22.5B
- EV / sales
- 23.51x
- EV / EBITDA
- 108.37x
- EV / EBIT
- 172.85x
- Market cap
- CNY 19.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026